Gilad Shabtai, 10% Owner at Eloxx Pharmaceuticals, Inc. (ELOX), bought 75,000 shares at $9.75 ($731K) on 2018-04-30, disclosed to the SEC on 2018-05-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |